Robert A. Levine

Robert A. Levine is a distinguished Professor of Medicine at Harvard Medical School and a senior physician at Massachusetts General Hospital, where he serves as Director of the Cardiac Ultrasound Laboratory and co-directs the Structural Heart Disease Program. He earned his medical degree from Harvard Medical School and completed his residency and cardiology fellowship at Massachusetts General Hospital. Dr. Levine's research focuses on the pathophysiology, diagnosis, and treatment of cardiac valve diseases and structural heart abnormalities, with particular emphasis on aortic stenosis, mitral regurgitation, and myocardial remodeling. His work integrates advanced imaging modalities—including echocardiography, digital pathology, and deformable image registration—with hemodynamic assessment to develop sex-specific prognostic markers and refine percutaneous interventions such as transcatheter valve therapies and caval-flow regulation. A central theme of his investigations is the quantification of myocardial fibrosis and collagen architecture in conditions like mitral valve prolapse, aiming to elucidate mechanisms of disease progression and identify therapeutic targets. Dr. Levine has authored over 680 peer-reviewed publications and maintains an h-index of 95, reflecting his substantial impact on the field. His recent contributions include pioneering studies on transvalvular flow rate in low-gradient aortic stenosis and the characterization of atrial functional mitral regurgitation, work that has been recognized through numerous invited lectures and editorial roles in leading cardiology journals. Representative publications include "Hydroxylase Cofactor Activity in Cerebrospinal Fluid of Normal Subjects and Patients with Parkinson's Disease", and "Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems.", which reflect their ongoing engagement with the field.